Comparative Pharmacology
Head-to-head clinical analysis: PEN VEE K versus PENTIDS 250.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PEN VEE K versus PENTIDS 250.
PEN-VEE K vs PENTIDS '250'
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Penicillin V binds to penicillin-binding proteins (PBPs) located on the bacterial cell wall, inhibiting the final transpeptidation step of peptidoglycan synthesis, leading to cell lysis.
Penicillin G binds to penicillin-binding proteins (PBPs) located on the bacterial cell wall, inhibiting transpeptidase activity and cell wall synthesis, leading to bacterial lysis.
250-500 mg orally every 6-8 hours for mild to moderate infections; up to 2 g/day for severe infections.
250 mg orally every 8 hours.
None Documented
None Documented
Terminal elimination half-life: 30-60 minutes in adults with normal renal function, prolonged to 3-10 hours in severe renal impairment.
0.5-1 hour (prolonged in renal impairment; requires dose adjustment when CrCl <30 mL/min)
Renal excretion of unchanged drug via glomerular filtration and tubular secretion accounts for 60-90% of elimination; biliary/fecal elimination is minimal (<10%).
Primarily renal (60-90% as unchanged drug via glomerular filtration and tubular secretion); minor biliary/fecal (10-30%)
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic